Rachel Denyer, M.D., MRCP
Washington D.C. Veterans Affairs Medical Center
Rachel Denyer, M.D., MRCP, is an infectious diseases physician at the Washington D.C. Veterans Affairs Medical Center and assistant professor in the School of Medicine and Health Sciences at George Washington University. She also serves as faculty for the Infectious Diseases Fellowship Program. She studied medicine at the University of Oxford in the United Kingdom, completed a residency in internal medicine at the University of Maryland Prince Georges Hospital Center and completed an infectious diseases fellowship in the combined GWU-Veterans Affairs Medical Center program.
Denyer serves as Associate Director of the Infectious Diseases Outpatient Clinic at the Washington D.C. Veterans Affairs Medical Center, mentors infectious diseases fellows in primary and infectious diseases care for persons with H.I.V. and rounds on the inpatient infectious diseases consult service with fellows and residents. She also researches H.I.V. and its interaction with aging and comorbidities, particularly hepatitis B infection, in collaboration with the D.C. Cohort, a citywide longitudinal cohort of persons living with H.I.V., and the nationwide Veterans Aging Cohort Study. In addition, she has a keen interest in global health and undertakes clinical research trials with the Centers for Disease Control and the Prevention T.B. Trials Consortium to improve treatment options worldwide for latent and active tuberculosis.
Denyer serves as Associate Director of the Infectious Diseases Outpatient Clinic at the Washington D.C. Veterans Affairs Medical Center, mentors infectious diseases fellows in primary and infectious diseases care for persons with H.I.V. and rounds on the inpatient infectious diseases consult service with fellows and residents. She also researches H.I.V. and its interaction with aging and comorbidities, particularly hepatitis B infection, in collaboration with the D.C. Cohort, a citywide longitudinal cohort of persons living with H.I.V., and the nationwide Veterans Aging Cohort Study. In addition, she has a keen interest in global health and undertakes clinical research trials with the Centers for Disease Control and the Prevention T.B. Trials Consortium to improve treatment options worldwide for latent and active tuberculosis.